» Articles » PMID: 15140533

Role of Collateral Circulation in the Acute Phase of ST-segment-elevation Myocardial Infarction Treated with Primary Coronary Intervention

Overview
Journal Eur Heart J
Date 2004 May 14
PMID 15140533
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The role of collateral flow in the first hours of infarction remains unclear. Our aim was to determine whether the presence of coronary collateral flow, as evidenced by angiography, has a beneficial effect on infarct size and left ventricular function in acute myocardial infarction (MI) treated by means of early percutaneous coronary intervention (PCI).

Methods: Between 1994 and 2001, 1059 patients with acute MI treated with primary PCI, TIMI (Thrombolysis in Myocardial Infarction) 0 or 1 flow at first contrast injection and technically adequate angiograms for collateral flow detection were analysed.

Results: Comparison of collateral flow grades 0, 1, and 2/3 showed that increased collateral flow was associated with a lower incidence of Killip class >/= 2 at presentation (12% vs. 10% vs. 3%, p for trend 0.02), less need for intra-aortic balloon pumping after PCI (17% vs. 13% vs. 5%, p for trend 0.005), better myocardial blush grade (MBG) in infarcts related with the left anterior descending coronary artery (LAD) (MBG3: 14% vs. 18% vs. 34%, p for trend 0.01), and smaller enzymatic infarct size (cumulative lactate dehydrogenase release 36 h after symptom onset [LDHQ(36)]) (1932+/-1531 U/l vs. 1870+/-1458 U/l vs. 1217+/-762 U/l, p for trend 0.041). These beneficial effects were particularly evident in LAD-related infarcts.

Conclusion: The presence of angiographically detectable collaterals has a protective effect on enzymatic infarct size and pre- and postintervention haemodynamic conditions in patients with acute MI treated by primary PCI, in particular when Rentrop grade 2/3 is present and the LAD is involved in the infarct.

Citing Articles

Do collaterals to infarct bed in STE-ACS patients undergoing emergent percutaneous coronary revascularization matter? An assessment of a prospective pool for in-hospital course.

Kumar R, Khan N, Mir A, Naseeb K, Ali G, Ashok A Indian Heart J. 2024; 76(5):358-363.

PMID: 39389259 PMC: 11584369. DOI: 10.1016/j.ihj.2024.10.006.


Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study.

Wu M, Pokreisz P, Claus P, Casazza A, Gillijns H, Caluwe E Basic Res Cardiol. 2024; 119(5):795-806.

PMID: 39090343 DOI: 10.1007/s00395-024-01069-7.


Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow.

Aarts B, Groenland F, Elscot J, Neleman T, Wilschut J, Kardys I Int J Cardiol Heart Vasc. 2023; 48:101254.

PMID: 37680547 PMC: 10481279. DOI: 10.1016/j.ijcha.2023.101254.


Osteopontin in Cardiovascular Diseases.

Shirakawa K, Sano M Biomolecules. 2021; 11(7).

PMID: 34356671 PMC: 8301767. DOI: 10.3390/biom11071047.


Does the extent of collaterals influence the severity of the myocardial injury as assessed by elevation in biomarkers?.

Dubey G, Sharma K, Patel I, Mansuri Z, Sharma V J Cardiovasc Thorac Res. 2021; 13(1):49-53.

PMID: 33815702 PMC: 8007895. DOI: 10.34172/jcvtr.2021.08.